Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3006291000168117 | Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3006301000168116 | Pralidoxime Iodide (Phebra) (pralidoxime iodide 500 mg / 20 mL) injection, 20 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 681754065 | |
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | Is a | Pralidoxime Iodide (Phebra) | true | Inferred relationship | Some | ||
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | Is a | pralidoxime iodide 2.5% (500 mg/20 mL) injection, ampoule | true | Inferred relationship | Some | ||
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | has intended active ingredient | pralidoxime iodide | true | Inferred relationship | Some | 681754064 | |
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | has Australian BoSS | pralidoxime iodide | true | Inferred relationship | Some | 681754064 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | has TPUU | True | Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | Inferred relationship | Some | 1 |
| Pralidoxime Iodide (Phebra) (pralidoxime iodide 500 mg / 20 mL) injection, 1 x 20 mL ampoule (containered trade product pack) | has TPUU | True | Pralidoxime Iodide (Phebra) 2.5% (500 mg/20 mL) injection, 20 mL ampoule | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Trade product unit of use reference set
FHIR